Die Entwicklung von Biomolekülen für die Grundlagenforschung und für Anwendungen in der Biotechnologie

Ph.D. Roger Y. TSIEN

Nobel Laureate in Chemistry; Professor of Pharmacology, Chemistry and Biochemistry, University of California; Investigator, Howard Hughes Medical Institute, San Diego

Received his A.B. in Chemistry and Physics, Harvard College Ph.D. in Physiology, University of Cambridge First Assistant, Associate, then full Professor, University of California, Berkeley Investigator, Howard Hughes Medical Institute and Professor, Departments of Pharmacology and of Chemistry & Biochemistry, University of California, San Diego Scientific Co-founder, Aurora Biosciences Corporation, which went public in 1997

1972
	until 1981 Research Fellow, University of Cambridge
1977
1981
1989
1996
	Dr. Tsien is best known for designing and building molecules that either report or perturb signal transduction inside living cells. These molecules, created by organic synthesis or by engineering naturally fluorescent proteins, have enabled many new insights into signaling via calcium, sodium, pH, cyclic nucleotides, nitric oxide, inositol polyphosphates, membrane and redox potential changes, protein phosphorylation, active export of proteins from the nucleus, and gene transcription. He is now developing new ways to target contrast agents and therapeutic agents to tumor cells and atherosclerotic plaques based on their expression of extracellular proteases.

Dr. Michael PRÜLLER

Stellvertretender Chefredakteur, Die Presse, Wien

Dr. juris, Paris-Lodron-Universität Salzburg Diplomstudium, Institut Européen des Hautes Etudes Internationales, Nizza Senior Consultant, PR- und Werbeagentur Ogilvy & Mather, Wien Ressortleiter, Wirtschaftsressort ("Economist"), Tageszeitung "Die Presse"

1986

1987

1996-1999

2000-2004